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a  b  s  t  r  a  c  t
Current  molecular  diagnostics  of human  pathogens  provide  limited  information  that  is  often  not  sufﬁ-
cient  for  outbreak  and  transmission  investigation.  Next  generation  sequencing  (NGS)  determines  the  DNA
sequence  of a complete  bacterial  genome  in a  single  sequence  run,  and  from  these  data,  information  on
resistance and virulence,  as well  as information  for typing  is obtained,  useful  for  outbreak  investigation.
The  obtained  genome  data  can  be  further  used  for the  development  of an  outbreak-speciﬁc  screening
test.  In this  review,  a general  introduction  to NGS  is  presented,  including  the  library  preparation  and  the
major  characteristics  of  the  most  common  NGS  platforms,  such  as  the  MiSeq  (Illumina)  and  the  Ion  PGMTM
(ThermoFisher).  An overview  of the software  used  for  NGS  data  analyses  used  at  the  medical  microbiology




more,  applications  of NGS  in  the  clinical  setting  are  described,  such as  outbreak  management,  molecular
case  ﬁnding,  characterization  and  surveillance  of  pathogens,  rapid  identiﬁcation  of  bacteria  using  the
16S-23S  rRNA  region,  taxonomy,  metagenomics  approaches  on  clinical  samples,  and the  determination
of  the  transmission  of  zoonotic  micro-organisms  from  animals  to humans.  Finally,  we  share  our  vision
on  the  use  of  NGS in  personalised  microbiology  in  the  near  future,  pointing  out speciﬁc  requirements.
© 2016  The  Author(s).  Published  by Elsevier  B.V.  This  is an  open  access  article under  the  CC  BY license. Introduction
Identiﬁcation and characterization of micro-organisms that
ause infections are crucial for successful treatment, recovery and
afety of patients. However, not every bacterial species can be suc-
essfully cultured in the diagnostic laboratory, and the available
olecular tests are unable to detect emerging genetic features in
uccessfully evolving pathogens that spread in humans, animals
nd the environment. Unrecognized pathogens can easily cause
ospital outbreaks, putting patients at risk during their hospital
dmissions.
During the last two decades, molecular diagnostic methods
ave experienced a rapid development and played an increasingly
∗ Corresponding author.
E-mail address: j.w.a.rossen@rug.nl (J.W.A. Rossen).
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168-1656/© 2016 The Author(s). Published by Elsevier B.V. This is an open access article(http://creativecommons.org/licenses/by/4.0/).
important role in medical microbiology laboratories (Buchan and
Ledeboer, 2014). These methods have reduced the turnaround time
from receiving the sample to the ﬁnal result, and made it possible
to detect non-cultivable pathogens. However, molecular methods
need a priori knowledge of the likely pathogenic species that could
be present in the sample. One of the molecular methods used
in medical microbiology laboratories is the sequence analyses of
genes or the whole genome of pathogens.
Sequence analyses can be used to answer different diagnostic
questions, such as the genetic relationship of either bacteria or
viruses, the detection of mutations in viral or bacterial genomes
leading to resistance against antivirals or antibiotics, identiﬁcation
of fungi through sequence analyses of the 18S ribosomal deoxyri-
bonucleic acid (rDNA) of the internal transcribed spacer (ITS) region
and identiﬁcation of bacteria through sequence analyses of the
16S rDNA (Bush, 2013; Deurenberg and Stobberingh, 2008; Liu
et al., 2012; Reiss et al., 2000). In general, Sanger sequencing is
 under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
































pFig. 1. A schematic overview of the general workﬂow
sed for this, preceded by ampliﬁcation of each gene or genomic
egion using speciﬁc primers. The same method can be applied
or the identiﬁcation of pathogens in clinical material. However,
his approach becomes problematic when clinical material is more
omplex and contains multiple species, such as faecal samples. In
uch cases, results obtained by Sanger sequencing are not reliable
nd make it hard or even impossible to identify speciﬁc pathogens.
urthermore, the cost of Sanger sequencing for these tasks is high,
nd the turnaround time is long.
The University Medical Center Groningen (UMCG) is one of the
argest university hospitals in The Netherlands with 1339 beds and
ore than 12,000 employees. The clinical microbiology diagnos-
ic laboratory at the UMCG receives around 5750 samples per year
or detailed molecular analysis, of which approximately 1500 are
ubjected to next generation sequencing (NGS) using two Illumina
iSeq and one Life Technologies Ion PGMTM sequencers. NGS was
ntroduced for routine diagnostics in 2014, and the majority of
ndications are outbreak investigation and genotyping of highly
esistant micro-organisms. NGS is requested by clinical micro-
iologists or infectious disease specialists in collaboration with
olecular microbiologists and infection control practioners.
. Next generation sequencing
NGS allows sequencing of the whole genome of numerous
athogens in one sequence run, either from bacterial isolates
f (different) patients, or from multiple species present in
atient material from one individual (metagenomics). Both the
nvestment- and the running costs of NGS have decreased dramat-
cally during the last decade (Dark, 2013; Sboner et al., 2011). A
reat advantage of NGS is that, in contrast to Sanger sequencing, a
ingle protocol can be used for all pathogens for both identiﬁcation
nd typing applications. Therefore, this technology has been proven
o be useful in medical microbiology laboratories and for infection
revention measures (Zhou et al., 2016). A schematic overview ofgnostic procedures including NGS in our laboratory.
the general workﬂow used for NGS analyses at the UMCG is shown
in Fig. 1.
For NGS, there is no need for target speciﬁc primers, which are
needed for Sanger sequencing. In a single run, the whole genome of
a pathogen is sequenced at random. Before sequencing, fragmen-
tation of the genome is performed, since the maximum length a
benchtop sequencer can sequence varies between 100 and 1000
bases and thus the genome cannot be sequenced in one part
(Junemann et al., 2013; Loman et al., 2012). An exception to this
are the third generation of sequencers, such as the MinION (Oxford
Nanopore) and the Sequel (Paciﬁc Biosciences), which can generate
larger fragments (more than 200 kb). However, these sequencers
are not yet used in the clinical microbiology laboratory, due to their
lack of affordability, the lower quality of the sequences, and the
low throughput. Therefore, NGS still requires the preparation of
libraries, in which fragments of DNA or RNA are fused to adapters
and barcodes to distinguish the DNA of the sequenced isolates after
sequencing, followed by a clonal ampliﬁcation, normalization and
sequencing. For this, a robust preparation of the libraries, which
contains a representative source of the DNA or RNA of the genome
under investigation, is needed (Head et al., 2014).
Fragmentation can be performed in several ways, either
mechanical, using, e.g., the Adaptive Focused Acoustics (AFA) tech-
nology from Covaris, followed by adaptor ligation, or enzymatic,
such as with transposons as used in the Nextera XT Library Prepa-
ration kit from Illumina. This method has the advantage that
fragmentation and fusion of the adaptors to the DNA or RNA frag-
ments are performed in one step, which makes it easier to automate
it. Besides that, less input DNA is needed. Mechanical fragmentation
has the advantage that the generation of the appropriate fragment
length is less inﬂuenced by factors present in the sample that inhibit
the enzymes used during the library preparation, and is therefore
very suitable for library preparations of direct sample material, such
as biopsies and faeces samples (Head et al., 2014).
NGS libraries may  contain errors that decrease the data quality,
and thus can disrupt the data interpretation. Detailed knowledge of
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Table 1
Properties of current NGS platforms.
Company Equipment Output/run (Gb) Maximum read length (bp) Reads (x106) Running time
Illumina MiniSeq 0.6–7.5 2 × 150 25 4–24 h
Illumina Miseq 0.3–15 2 × 300 25 5–55 h
Illumina NextSeq 20–120 2 × 150 130/400 12–30 h
Illumina HiSeq 3000 125–700 2 × 150 2500 <1–3.5 days
ThermoFisher Ion PGMTM 0.03–2 200–400 0.4–5.5 2–7 h
ThermoFisher Ion 5STM 0.6–15 200–400 3–80 2.5–4 h
ThermoFisher Ion 5STM XL 0.6–15 200–400 3–80 <24 h
Oxford Nanopore MinION 21–42 230,000–300,000 2.2–4.4 1 min–48 h
Paciﬁc  Biosciencesa Sequel 0.75–1.25 >20,000 370,000 30 min–6 h














































Da The Paciﬁc Biosciences data are per smart cell; both the Sequel and the RSII can
he kind of errors is important to ﬁnd ways to avoid the introduc-
ion of such errors and for the correct interpretation of the NGS data.
lmost all separate steps in the sequence procedure can introduce
rrors. This is especially true with RNA sequencing that is techni-
ally more challenging compared to DNA sequencing (Junemann
t al., 2013; Loman et al., 2012).
At the moment, a number of NGS platforms are available. The
ost important properties of several NGS platforms, such as out-
ut and fragment length, are presented in Table 1 (Bertelli and
reub, 2013; Dark, 2013; Junemann et al., 2013; Loman et al., 2012).
he different NGS platforms use different sequencing technologies.
llumina sequencers use sequencing by synthesis of ﬂuorescent,
eversible terminators, and ThermoFisher sequencers use semi-
onductor sequencing that measure a change in pH during the
ncorporation of nucleotides. Paciﬁc Biosciences use ﬂuorescent
ucleotides in their single molecule real-time (SMRT) technology,
nd Oxford Nanopore platforms use ionic current sensing, in which
NA is guided through nano-pores, thereby changing the current in
 way that is speciﬁc for the type of nucleotide. Extensive informa-
ion on the different NGS platforms and their method of sequencing
re available on the companies’ websites. Due to the technological
evelopments, the cost of NGS decreased between 2001 and 2015,
hile the speed of sequencing has increased (Dark, 2013; Sboner
t al., 2011).
. Software for data analyses
The biggest challenge concerning the introduction of NGS in
he clinical microbiology laboratory is the data analyses. Nonethe-
ess, even with little knowledge of bioinformatics, it is possible
o perform NGS data analyses for diagnostic purposes, using the
umerous user-friendly software packages available (Edwards
nd Holt, 2013). However, for more in-depth analysis, scientiﬁc
nowledge is required on the genomic features and the biological
ackground of the micro-organism under investigation.
After sequencing, the sequenced fragments (reads) can be de
ovo assembled (genome assembly). Hereby, the reads are aligned
gainst each other without the use of a reference organism. In gen-
ral, the larger the fragments, the easier and more accurate the
enome assembly will be. Software packages (Table 2), such as
LC Genomic Workbench (Qiagen), SPAdes and Velvet, are used in
ur laboratory to assemble the genomes. The genetic relationship
etween isolates can be investigated by using a gene-by-gene com-
arison using a multi-locus sequencing typing (MLST) approach,
ither by studying the conserved core genome (cgMLST), or the
hole genome (wgMLST), which includes a set of variable acces-ory genes. Several software packages, such as SeqSphere (Ridom)
nd BioNumerics (Applied Maths, Biomérieux), or online tools,
uch as EnteroBase and BIGSdb (Bacterial Isolate Genome Sequence
atabase) (Jolley and Maiden, 2010), can be used for this approach.–16 smart cells in one run.
Furthermore, the use of an established cgMLST scheme allows the
introduction of a common nomenclature for genetically related
strains (de Been et al., 2015; Kohl et al., 2014; Ruppitsch et al.,
2015). At the moment, it is not clear how many alleles two genomes
may  differ to call them (close to being) identical. The same prob-
lem applies when comparing two  genomes using single-nucleotide
polymorphisms (SNP) typing (Maiden et al., 2013). However, the
term genetic distance (the proportion of different alleles, calculated
by dividing the number of allele differences by the total number
of genes shared by two sequences) has been recently introduced,
and enables unbiased comparisons for different cgMLST or wgMLST
schemes as well as the deﬁnition of thresholds by studying col-
lections of epidemiologically and non-epidemiologically related
strains (Kluytmans-van den Bergh et al., 2016b). An advantage of
cgMLST and wgMLST is that there is compatibility between cgMLST,
wgMLST and older typing methods, since both BioNumerics and
SeqSphere give the sequence type (ST) as determined by conven-
tional MLST and the spa type (in case of Staphylococcus aureus).
Several possibilities to analyse NGS data can be found on the
website of the Center for Genomic Epidemiology. For the detection
of virulence- and resistance genes, VirulenceFinder and ResFinder,
can be used. Alternatively, the Comprehensive Antibiotic Resis-
tance Database (CARD) and the Virulence Factor Database (VFDB)
can be used to obtain data on resistance and virulence genes. With
these online tools, both the non-assembled sequence data and the
assembled genome can be uploaded. However, the results obtained
through these websites needs conﬁrmation using other methods.
In case of S. aureus,  it has been reported that there is a good corre-
lation between the presence of resistance genes and its phenotypic
resistance pattern (Aanensen et al., 2016).
Further comparative genome studies are possible using Artemis
Comparison Tool (ACT) (Carver et al., 2005), Artemis (Carver et al.,
2012), and DNA plotter (Carver et al., 2009) from the Sanger Insti-
tute.
Speciﬁc research questions require knowledge of Unix-systems
and to handle the large diversity of bioinformatics software pack-
ages available for it. Furthermore, software for the analyses of
metagenomics data is available, such as the MEGAN Alignment Tool
(Huson et al., 2007). In contrast to the decreased sequencing costs,
the costs for data storage and data analyses have increased due the
generation of large amounts of data, and the complexity of it.
4. NGS in clinical microbiology
NGS is already applied in several medical microbiology labo-
ratories, including our laboratory at the UMCG, where it is used
for outbreak management, molecular case ﬁnding, characterization
and surveillance of pathogens, rapid identiﬁcation of bacteria using
the 16S-23S rRNA region, taxonomy, metagenomics approaches
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Table  2
Software packages frequently used for NGS data analyses in our laboratory.
Application Software Link Note
Annotation Prokka www.vicbioinformatics.com
RAST http://rast.nmpdr.org
Assembly BioNumerics www.applied-maths.com Commercial software
CLC  Genomic Workbench www.clcbio.com Commercial software
SeqSphere www.ridom.de Commercial software
SPAdes http://bioinf.spbau.ru/spades Unix-based
Velvet www.ebi.ac.uk/∼zerbino/velvet Unix-based
Data  quality check BaseSpace https://basespace.illumina.com Commercial software
BioNumerics www.applied-maths.com Commercial software












SNP calling BioNumerics www.applied-maths.com Commercial software
CLC  Genomic Workbench www.clcbio.com Commercial software
Samtools www.htslib.org
SeqSphere www.ridom.de Commercial software
Typing (wgMLST) BIGSdb http://bigsdb.readthedocs.io
BioNumerics www.applied-maths.com Commercial software
CLC  Genomic Workbench www.clcbio.com Commercial software
EnteroBase https://enterobase.warwick.ac.uk
SeqSpere www.ridom.de Commercial software
Virulence VFDB www.mgc.ac.cn/VFs
VirulenceFinder www.genomicepidemiology.org
Visualisation & ACT www.sanger.ac.uk/science/tools





























n clinical samples, and the determination of the transmission of
oonotic micro-organisms from animals to humans.
.1. Outbreak management
The advantages of using whole genome sequencing (WGS)-
ased typing is promoting the implementation of NGS for
pidemiological studies and public health investigations. It is espe-
ially important and helpful in outbreak detection and monitoring
he evolution and dynamics of multi-drug resistant pathogens
ECDC, 2016). Several studies illustrated the usefulness of WGS-
ased typing for disclosing and tracing the dissemination of
merging pathogens. Indeed, it was used in our hospital to charac-
erize a newly emerging CTX-M-15 producing K. pneumoniae clone
ith sequence type (ST) 1427 (Zhou et al., 2015b). In addition, the
ransmission of a CTX-M-15-producing ST15 Klebsiella pneumoniae
etween patients treated in a single centre and the subsequent
nter-institutional spread by patient referral has been traced by
enomic phylogenetic analysis (Fig. 2). The investigation allowed
he early detection of a K. pneumoniae high-risk-clone (HiRiC) with
rolonged circulation in the regional patient population (Zhou et al.,
016). Furthermore, this study showed the usefulness of a unique
arker approach, in which a clone-speciﬁc PCR was developed




In addition to outbreak tracing and characterization, the use
of WGS  also allows the implementation of control measures to
avoid the spread of resistant bacterial clones. An outbreak of a
colistin-resistant carbapenemase-producing K. pneumoniae (KPC)
with inter-institutional spread in The Netherlands, was  controlled
by transferring all positive residents to a separate location out-
side the institution, where a dedicated team cared for the patients
(Weterings et al., 2015).
Apart from multidrug-resistant bacteria, WGS  is also useful and
applicable to characterize highly-virulent bacteria, such as shiga
toxin-producing Escherichia coli (STEC) O104:H4. This bacterium
has emerged as an important pathogen and has been responsible for
large outbreaks. However, there has been little information about
the evolutionary history and genomic diversity of it. Phylogenetic
analysis of outbreak and non-outbreak related isolates using WGS
provided an evolutionary context and revealed lineage-speciﬁc
markers, indicative for selective pressure and niche adaptation
(Zhou et al., 2015a). In addition, core-genome phylogenetic analy-
sis of shiga toxin-producing Enteroaggregative E. coli (EAEC Stx2a+)
O104:H4 showed different clustering and different resistance and
virulence patterns depending on the time of isolation (Ferdous
et al., 2015). These studies reﬂect the importance of NGS as a high
discriminatory power tool to differentiate between clones with
speciﬁc properties and to use the obtained knowledge for patient
management, infection prevention and evolutionary studies.
20 R.H. Deurenberg et al. / Journal of Biotechnology 243 (2017) 16–24
Fig. 2. The transmission route was reconstructed by epidemiological and genomic data. Each node represents a patient, and an arrow indicates a possible transmission
event  from one patient to another. The blue arrow with solid line represents a direct transmission event supported by both epidemiological data and genetic data, the blue
arrow  with dash line represents an indirect transmission (e.g. via environment) supported by epidemiological data, and the red arrow indicates the equally parsimonious
t etic d
t t a se
































wransmission link which cannot be resolved by neither epidemiological data nor gen
he  distance between institutions is indicated. The red star represents an outbreak a
016). (For interpretation of the references to color in this ﬁgure legend, the reader
.2. Molecular case ﬁnding
Molecular case deﬁnitions of outbreak isolates are commonly
sed in outbreak investigations. NGS databases can retrospectively
e searched for cases in complex and comprehensive outbreaks.
his may  result in detection of cases that would not have been found
y traditional epidemiological investigation. In a study, a New Delhi
etallo-ß-lactamase-5 (NDM-5)-producing K. pneumoniae ST16
train was isolated from a Dutch patient from a long-term care
acility without a recent history of travel abroad. Molecular case
nding showed that the Dutch strain was clonally related to strains
solated from four patients in Denmark in 2014 (Bathoorn et al.,
015), but there were no obvious epidemiological links between
he cases in the Danish and Dutch hospitals. European national
urveillance centres were contacted for molecular case ﬁnding in
heir NGS databases, but no additional cases were detected.
Other examples of molecular case ﬁnding in NGS databases
ave been reported after the discovery of the plasmid resistance
ene mcr-1,  responsible for colistin resistance, in life-stock and
ospitalised patients. Its introduction in European countries was
nvestigated using a retrospectively search for the mcr-1 gene in
GS databases. This resulted in the detection of cases in Denmark,
ermany, and The Netherlands (Falgenhauer et al., 2016; Hasman
t al., 2015; Kluytmans-van den Bergh et al., 2016a). In The
etherlands, more than 2000 Dutch Enterobacteriaceae isolates
ere screened within a few hours to reveal the presence of the
cr-1 gene (Kluytmans-van den Bergh et al., 2016a). So, NGS data
lready present can be used to screen for the presence of new
antibiotic resistance) genes (in silico screening).
.3. Characterization and surveillance of pathogens
The current routine procedure for pathogen characterization is
ased on a large variety of bacteriological, biochemical and molec-
lar methods, making this procedure laborious, time-consuming,
nd expensive. NGS may  serve as a perfect one-step tool to study
 broad range of pathogen characteristics and is applicable on a
ide range of pathogens (Aanensen et al., 2016; Fournier et al.,ata. The inter-institutional transfer of the patient is shown by dash lines, on which
condary hospital, but the isolates were unavailable for further research (Zhou et al.,
erred to the web version of this article.)
2014; Hasman et al., 2014). Knowledge of the virulence proﬁle of a
pathogen is crucial to predict the disease severity, outcome of the
infection and to allow risk assessment during the early onset of the
disease. WGS  has the potential to make a substantial contribution
to determine the presence of virulence factors using several online
tools, since it is not restricted to a speciﬁc gene (Franz et al., 2014;
Laabei et al., 2014).
In a large cohort study, WGS  was  used for molecular charac-
terization of STEC, resulting in a clear understanding about the
population structure and genomic plasticity of STEC in the regions
around the cities Groningen and Rotterdam in The Netherlands
(Ferdous et al., 2016). All relevant information could be extracted in
silico from the sequence data, including genotype, serotype, MLST
proﬁle, virulence and antibiotic resistance proﬁles, and the phylo-
genetic background to obtain the overall molecular features with
a high discrimination among closely related strains. NGS allowed
to characterize and compare many strains in detail within a rela-
tively short time span. Thus, for a rapid and improved molecular
epidemiological surveillance of pathogens at regional and national
scale, the role of WGS  is undeniable.
NGS is also helpful in detection of novel resistance genes in
bacteria, both in current as well as in historical strain collections.
Novel variants of antibiotic resistance genes (ARG) can be identiﬁed
using NGS, and further experiments can be performed to determine
if these genes are indeed responsible for the observed antibiotic
resistance pattern (Nijhuis et al., 2015).
4.4. Targeted NGS of the 16S-23S rRNA cluster region for rapid
bacterial identiﬁcation in clinical specimen
NGS allows culture-free detection of a theoretically unlimited
number of pathogens and thus provides insight in the full micro-
biome. Metagenomics will be the ultimate approach in detecting all
micro-organisms (e.g. bacteria, viruses, fungi) in a clinical sample
(Hasman et al., 2014). However, analysis of large datasets requires
a combination of bioinformatics skills and computational resources
that is nowadays mostly absent in diagnostic medical microbiolog-
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onsuming as the turnaround time is approximately four to ﬁve
ays.
To ﬁll the gap between the conventional methods (culture and
CR) and metagenomics, a culture-free approach using targeted
GS appears to be an excellent approach to detect and identify
acterial species. Compared to metagenomics, it is faster, less com-
licated and cheaper, and therefore more likely to get implemented
n diagnostic laboratories within a short timeframe. The 16S rRNA
ene sequence has been proven to be a reliable genetic marker as
t is present in all bacteria, and the function has not changed over
ime (Patel, 2001). It can be applied directly on clinical materials
nd has proven to be a valuable supplementary test in daily clinical
ractice (Schuurman et al., 2004; Srinivasan et al., 2012). However,
igh sequence similarities in this gene between certain bacterial
pecies do not always lead to an unequivocal identiﬁcation (Kalia
t al., 2016).
Recently, we developed an innovative culture-free 16S-23S
RNA NGS approach for the detection and identiﬁcation of bacte-
ial species in clinical samples. The method proved to be superior
o other commonly used identiﬁcation methods and correctly iden-
iﬁed pathogens in urine samples that were also identiﬁed as the
ause for urinary tract infections with conventional culture (Sabat
t al., 2016). Furthermore, the method allows simultaneous iden-
iﬁcation of several pathogens in clinical materials that previously
ould have remained uncultured and PCR negative. Clearly, this
ill have an enormous clinical impact and will have consequences
or patient treatment, including improved antibiotic treatment.
inally, this method will allow clinical microbiology laboratories to
mplement NGS in their routine diagnostic laboratory and to keep
p with technological and bioinformatics developments required
o be able to implement metagenomics in diagnostics in the future.
.5. WGS  and taxonomy
In the eighteenth century, Linnaeus (Linnaeus, 1735) provided
uidelines for classiﬁcation of living creatures based on their phe-
otypic features. A century later, Darwin added the phylogenetic
omponent to the taxonomy (Darwin, 1859). The taxonomy of
acterial species changed dramatically by the introduction of 16S
RNA gene sequencing. Nowadays, WGS  is also used to identify and
escribe new species. By comparing the whole genome sequences
f different species with each other, the limited taxonomic reso-
ution of only the 16S rRNA gene can be overcome (Tindall et al.,
010). Another change in taxonomy may  be expected when WGS
s used for revealing the taxonomy of bacteria.
Indeed, using WGS  for taxonomy purposes allows to include
ore genes to delineate between species than the classical
NA–DNA hybridization or 16S rRNA sequencing methods thereby
mproving the resolution. Furthermore, as WGS  can be used to
alculate taxonomic trees based on the whole genome-sequence
lignment of all the genes present in the core genome, a more
obust tree will be obtained (Daubin et al., 2001). It has already
een proposed that descriptions of new taxa should also include a
raft genome sequence, with at least 20 times coverage (Thompson
t al., 2013).
.6. Metagenomics in clinical microbiology
As already mentioned, NGS can be applied directly to clinical
pecimens. Not only by using a targeted NGS approach, but also
y sequencing the DNA or RNA from patient samples by shotgun
etagenomics sequencing (Fig. 3). Using this method, it is possi-
le to investigate the presence of pathogens and the presence of
irulence and/or resistance genes in one sequence run.
A recent study compared the detection of viruses in known
espiratory virus-positive samples and not previously analysedtechnology 243 (2017) 16–24 21
nasopharyngeal swabs by an RNA sequencing-based metagenomics
approach with a more conventional molecular method. The data-
analyses was  performed using Taxonomer, a rapid and interactive,
web-based metagenomics data-analyses tool (Flygare et al., 2016).
Overall, the metagenomics approach had a high agreement with
the molecular method, detected viruses not targeted by the molec-
ular method, and yielded epidemiologically and clinically relevant
sequence information (Graf et al., 2016).
Apart from identifying pathogens, a metagenomics approach
can also be used to study the resistome. The gut is a known reservoir
for antibiotic resistance genes (ARG), and treatment with antibi-
otics has an impact on the intestinal resistome, which can lead to
horizontal gene transfer and the selection of resistant bacteria. A
study at the University of Tübingen investigated the presence of
ARGs in the gut over a six-day period of ciproﬂoxacin treatment in
two individuals using metagenomics. Furthermore, this study pre-
sented a novel method for analysing the determination of antibiotic
selection pressure, which can be used in hospitals to compare ther-
apeutic regimens and their effect on the intestinal resistome. This
information is important for clinicians to choose antibiotic therapy
with a low selective antibiotic pressure on the patient’s bacteria in
the gut, possibly resulting in a decreased dissemination of antibiotic
resistant bacteria (Willmann et al., 2015).
4.7. Determining the transmission of zoonotic micro-organisms
from animals to humans
NGS will also reveal more knowledge on zoonotic transmission
of micro-organisms. The ﬁrst studies on this topic were based on
low discriminatory methods, such as serotyping (Tenover et al.,
1997). More recently, studies using higher discriminatory tech-
niques, such as pulsed-ﬁeld gel electrophoresis or multi-locus
variable number tandem repeat analysis, were used to detect spe-
ciﬁc bacterial clones in animals and humans (Sabat et al., 2013).
However, much remains to be understood, especially when it
comes to the frequency of transmission (e.g. single contact or
repeated contact with animals or animal products), risk factors
associated with the acquisition of a zoonotic microorganism (e.g.
risk conducts, such as animal kissing in companion animals, or stool
handling in farm animals) and how the use of antibiotics in animals
affects the transfer of pathogenic bacteria to humans.
NGS brings a new perspective to these topics. A higher discrimi-
natory power will reveal differences in previously indistinguishable
animal and human bacterial strains. This together with epidemi-
ological information allows source tracing of potential zoonotic
infections (Harrison et al., 2013). In addition, NGS allows a com-
prehensive analysis of how antibiotic use manipulates speciﬁc
microbiota and the consequences for interspecies transmission and
will increase the knowledge on microbial evolution through the
analysis of bacterial genomes, namely the variable regions, which
usually determine host-adaptation and the potential of spread to
different hosts (Harrison et al., 2014; Price et al., 2012).
As the patients’ safety is depending on its environment, includ-
ing their contact with food and animals, research projects are
currently performed in the UMCG to understand the dynamics
of transmission of bacteria between humans, animals and the
environment. These studies are performed in collaboration with
veterinary research groups and focus on anti-microbial resistant
bacteria. In one such study, the mcr-1 gene was detected by WGS
to be present in three E. coli strains isolated from retail chicken
meat. Although none of the human strains carried this gene, two
of the three strains belonged to ST117, a common clone in both
poultry and humans, representing a potential public health concern
(Kluytmans-van den Bergh et al., 2016a).












aFig. 3. An example of an output of a metagenomics approach of a f
. Conclusion and outlook
For generating NGS data from samples originating from humans,
nimals, food and the environment, the same laboratory proto-
ol for library preparation can be used, and, after data analyses,
nformation on the presence of speciﬁc antibiotic resistance and
irulence genes is obtained. Furthermore, NGS makes it possible
o standardise typing methods for pathogens (“one test ﬁts all”).
he role of NGS in medical microbiology laboratories will increase
uring the next years, not only for research, but also, and more
mportantly, for molecular diagnostics, infection prevention, the
nvestigation of outbreaks by the use of a unique outbreak marker
pproach, the characterization and surveillance of pathogens, theample. The different colours represent different bacterial families.
detection of novel resistance genes and for the application of a
metagenomics approach on clinical samples.
However, further studies are required to improve the work-
ﬂow for NGS, in particular shorten the turnaround time for the
library preparation and the runs on the NGS platforms, and, at
the same time, further reducing costs. Next, automatic pipelines
for data-analyses and easy-to-use software for metagenomics have
to be developed. Additionally, more established typing schemes
for pathogens and cut-off values for these typing schemes have
to be established, leading to reference databases with genetic
and metadata, and (inter)regional and international collaborations.
Importantly, external quality controls for proﬁciency testing have
to be developed. Only then will patient guidance and infection con-
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s well as targeted antibiotic therapy using NGS data become a
ossibility, leading to personalised microbiology.
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